Clinical and Immunological Long-term Follow-up of Patients With Pemphigus Included in the "RITUXIMAB 3" Trial

NCT03790293 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: Rituximab
DRUG: corticosteroids'therapy

Sponsor

University Hospital, Rouen